Safety and Efficacy of Bepotastine Besilate Nasal Product in Seasonal Allergic Rhinitis Patients.
Phase of Trial: Phase I/II
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Bepotastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Bausch & Lomb
- 15 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2010 New source identified and integrated (ClinicalTrials.gov).
- 15 Oct 2010 Actual end date 1 Aug added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History